Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma
Seoul National University Hospital
Seoul National University Hospital
University of Nebraska
PharmaMar
University of Wisconsin, Madison
AGC Biologics S.p.A.
Ziekenhuis Oost-Limburg
European Lung Cancer Working Party
European Lung Cancer Working Party
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)